News & Updates

No benefit to SGLT2 inhibitor therapy in hospitalized COVID-19 patients

15 Sep 2024 by

Adding sodium–glucose co-transporter-2 (SGLT2) inhibitors to usual care in the treatment of hospitalized patients with COVID-19 does not necessarily lead to improved survival, according to the results of a meta-analysis.

No benefit to SGLT2 inhibitor therapy in hospitalized COVID-19 patients

15 Sep 2024

Fewer CV events after COVID-19 vaccine-related myocarditis

13 Sep 2024 by

In a nationwide French cohort study, myocarditis attributed to COVID-19 mRNA vaccination causes fewer cardiovascular (CV) events at 18 months of follow-up than that attributed to SARS-CoV-2 infection or myocarditis of conventional aetiologies.

Fewer CV events after COVID-19 vaccine-related myocarditis

13 Sep 2024

No link between COVID-19 vaccines and new-onset seizures

12 Sep 2024

Individuals who have been vaccinated against COVID-19 appear to have a risk of new-onset seizure that is similar to that observed among unvaccinated individuals, according to the results of a meta-analysis.

No link between COVID-19 vaccines and new-onset seizures

12 Sep 2024

Nutritional support team system may prolong survival in sepsis

12 Sep 2024

A multidisciplinary nutritional support team (NST) can help improve the survival outcomes in patients with sepsis, according to a study. Such improvements are more pronounced in those aged ≥65 years who were admitted to the ICU.

Nutritional support team system may prolong survival in sepsis

12 Sep 2024

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

12 Sep 2024 by

The ENVIE* study demonstrates the real-world effectiveness of nirsevimab against hospitalization for bronchiolitis associated with respiratory syncytial virus (RSV) among infants <12 months of age in France.

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

12 Sep 2024

Common antibiotics linked to serious skin reactions

11 Sep 2024 by

Several classes of commonly prescribed oral antibiotics appear to carry an increased risk of serious cutaneous adverse drug reactions (cADRs), according to a study.

Common antibiotics linked to serious skin reactions

11 Sep 2024

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

11 Sep 2024

Children with invasive fungal sinusitis may benefit from early diagnosis, aggressive surgical intervention, and combined antifungal therapy to achieve better outcomes, suggests a study.

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

11 Sep 2024

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

10 Sep 2024

In the treatment of children with brucellosis, the most prescribed antibiotic therapy is sulfamethoxazole-trimethoprim plus rifampicin, reports a study.

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

10 Sep 2024

Pyomyositis a challenging diagnosis in nontropical countries

09 Sep 2024 by

Diagnosis of pyomyositis, a bacterial muscle infection, among hospitalized children and adolescents with musculoskeletal pain remains difficult for many clinicians and requires greater awareness, according to a recent study.

Pyomyositis a challenging diagnosis in nontropical countries

09 Sep 2024

Birth month predicts severe RSV infection in infants

08 Sep 2024 by

Infants born prior to or within the early weeks of a respiratory syncytial virus (RSV) epidemic must be prioritized to prevent the development of a clinical severe infection, suggests a study that used machine-learning algorithms.

Birth month predicts severe RSV infection in infants

08 Sep 2024

News & Updates

Filter by Specialty:

Specialty:

No benefit to SGLT2 inhibitor therapy in hospitalized COVID-19 patients

No benefit to SGLT2 inhibitor therapy in hospitalized COVID-19 patients

Fewer CV events after COVID-19 vaccine-related myocarditis

Fewer CV events after COVID-19 vaccine-related myocarditis

No link between COVID-19 vaccines and new-onset seizures

No link between COVID-19 vaccines and new-onset seizures

Nutritional support team system may prolong survival in sepsis

Nutritional support team system may prolong survival in sepsis

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

Common antibiotics linked to serious skin reactions

Common antibiotics linked to serious skin reactions

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

Pyomyositis a challenging diagnosis in nontropical countries

Pyomyositis a challenging diagnosis in nontropical countries

Birth month predicts severe RSV infection in infants

Birth month predicts severe RSV infection in infants